Management of Infantile Spasms During the COVID-19 Pandemic | Zendy

Zachary M. Grinspan | Zendy; John R. Mytinger | Zendy; Fiona M. Baumer | Zendy; Michael A. Ciliberto | Zendy; Bruce H. Cohen | Zendy; Dennis Dlugos | Zendy; Chellamani Harini | Zendy; Shaun A. Hussain | Zendy; Sucheta M. Joshi | Zendy; Cynthia Keator | Zendy; Kelly G. Knupp | Zendy; Patricia E. McGoldrick | Zendy; Katherine Nickels | Zendy; Jun Park | Zendy; Archana Pasupuleti | Zendy; Anup D. Patel | Zendy; Asim Shahid | Zendy; Renée A. Shellhaas | Zendy; Daniel W. Shrey | Zendy; Rani K. Singh | Zendy; Steven M. Wolf | Zendy; Elissa Yozawitz | Zendy; Christopher J. Yuskaitis | Zendy; Jeff L. Waugh | Zendy; Phillip L. Pearl | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Management of Infantile Spasms During the COVID-19 Pandemic

Author(s) -

Zachary M. Grinspan,

John R. Mytinger,

Fiona M. Baumer,

Michael A. Ciliberto,

Bruce H. Cohen,

Dennis Dlugos,

Chellamani Harini,

Shaun A. Hussain,

Sucheta M. Joshi,

Cynthia Keator,

Kelly G. Knupp,

Patricia E. McGoldrick,

Katherine Nickels,

Jun Park,

Archana Pasupuleti,

Anup D. Patel,

Asim Shahid,

Renée A. Shellhaas,

Daniel W. Shrey,

Rani K. Singh,

Steven M. Wolf,

Elissa Yozawitz,

Christopher J. Yuskaitis,

Jeff L. Waugh,

Phillip L. Pearl

Publication year - 2020

Publication title -

journal of child neurology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.661

H-Index - 105

eISSN - 1702-6075

pISSN - 0883-0738

DOI - 10.1177/0883073820933739

Subject(s) - pandemic , covid-19 , telemedicine , medicine , health care , neurology , pediatrics , psychiatry , political science , outbreak , pathology , disease , infectious disease (medical specialty) , law

Circumstances of the COVID-19 pandemic have mandated a change to standard management of infantile spasms. On April 6, 2020, the Child Neurology Society issued an online statement of immediate recommendations to streamline diagnosis and treatment of infantile spasms with utilization of telemedicine, outpatient studies, and selection of first-line oral therapies as initial treatment. The rationale for the recommendations and specific guidance including follow-up assessment are provided in this manuscript. These recommendations are indicated as enduring if intended to outlast the pandemic, and limited if intended only for the pandemic health care crisis but may be applicable to future disruptions of health care delivery.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research